view
|
Ointment and gel manufacturing unit
On 28 November 2012, JSC «Grindeks» unveiled Ointment and gel manufacturing unit, which is one of the most modern in the Baltic States and meets world-class standards of pharmaceutical manufacturing. Altogether 2.5 million lats were invested in the manufacturing unit of ointments and gels, out of which the co-financing of the EU structural funds – 448.67 thousand lats. The investments are planned to be recovered within 2 years.
|
view
|
Final dosage forms manufacturing unit
Expansion and modernization of the new final dosage forms plant is the most considerable investment project in the history of the concern. A total of LVL 9.1 million have been invested in construction of the new plant. LVL 6.4 million of it have been invested in the building, while LVL 2.7 milllion – in technological devices and equipment.
|
view
|
UDCA active pharmaceutical ingredient’s manufacturing unit
On 16 June 2011, JSC «Grindeks» unveiled UDCA, an active pharmaceutical ingredient, manufacturing unit.
|
view
|
Clinical trial on Mildronate®
In February 2010 «Grindeks» informed that it has successfully finished the clinical trial on the influence of the brand product Mildronate® on the treatment of angina. International clinical trial was carried out in the cooperation with the experienced clinicists, scientific experts and international contract research organisations corresponding with the ICH/ GCP (Good clinical practiсe) and the EU legislation for the clinical trials of I - IV phases. A randomized, multinational, multicenter, double blind, placebo-controlled clinical trial with Mildronate® was performed in 37 research centres in Latvia, Lithuania, Russia and Ukraine. Efficiency and safety of Mildronate® in long term treatment of angina was investigated. «Grindeks» altogether has invested 1.6 million lats in the research.
|
view
|
Opening of industrial sewage purification plant
On 4 June 2009, on the eve of the World Environment Day, JSC «Grindeks» opens new industrial sewage purification plant where the principle of biological purification has been implemented and the most modern technologies installed. The principle of biological purification is the most modern and environmentally friendly way of sewage purification in chemical industry. In total, 2.5 million lats were invested in the project.
|
view
|
Construction of a waste water purification plant
On June 4, 2009, on the eve of the World Environment Day, JSC «Grindeks» opened new industrial sewage purification plant where the principle of biological purification has been implemented and the most modern technologies installed. The principle of biological purification is the most modern and environmentally friendly way of sewage purification in chemical industry. In total, 2.5 million lats were invested in the project.
|
view
|
Construction of Ursodeoxycholic acid manufacturing unit.
In order to ensure regular development and manufacturing of ursodeoxycholic acid, «Grindeks» has started construction of a new manufacturing unit. It is planned to invest almost 6 million lats in the project in total. In February 2010 the company signed an agreement with Investment and Development Agency of Latvia on co-financing of 2.8 million lats from the European Regional Development Fund for construction of Ursodeoxycholic acid manufacturing unit.
|
view
|
Opening of the active pharmaceutical ingredient Analytical Scale-up Laboratory
On 19 June 2007, «Grindeks» unveiled the new Analytical Scale-up Laboratory that is the only laboratory of this kindin the Baltic States and one of the some in Eastern Europe. Laboratory project was developed within five years; 3.2 million lats were invested in the realisation of the project. Within the frameworks of the project additional fundings from EU European Regional Development Fund amounting 1.5 million lats.
|
